Flurry of Federal and State Probes Target Insulin Drugmakers

by Nov 10, 2017News Coverage0 comments

Kaiser Health News looked at the alarming rise in insulin drug prices that is causing many Americans to struggle to pay for their medicine.  As part of their analysis, the journalist talked with our own Jim Yocum and used Connecture data to demonstrate patterns in this critical issue. Read the full article here.